S. Karger AG

SHERPA: Unknown

People

  1. Bodei
    Bodei
  2. Drilon
    Drilon
  3. Motzer
    Motzer
  4. Abou-Alfa
    Abou-Alfa
  5. Chaganti
    Chaganti
  6. Lin
    Lin
  7. Tang
    Tang
  8. Clarkson
    Clarkson
  9. Janjigian
    Janjigian
  10. Marghoob
    Marghoob

Groups

  1. Department of Medicine (279)
  2. Solid Tumor Oncology Division (160)
  3. Hematologic Malignancies, Division of (107)
  4. Center for Hematologic Malignancies (103)
  5. Survivorship Research (59)
  6. Gastrointestinal Oncology Service (57)
  7. Sloan Kettering Institute Postdocs (55)
  8. Surgery (54)
  9. Sloan Kettering Institute Faculty (47)
  10. Thoracic Oncology (45)
Search Within
Formats
  1. Meeting Abstract (332)
  2. Journal Article (254)
  3. Book Section (20)
  4. Review (15)
  5. Conference Paper (10)
  6. Book Whole (1)
  7. Editorial (1)
Groups
  1. Department of Medicine (279)
  2. Solid Tumor Oncology Division (160)
  3. Hematologic Malignancies, Division of (107)
  4. Center for Hematologic Malignancies (103)
  5. Survivorship Research (59)
  6. Gastrointestinal Oncology Service (57)

More Groups

People
  1. Lisa Bodei (32)
  2. Alexander Drilon (23)
  3. Robert Motzer (23)
  4. Ghassan Abou-Alfa (18)
  5. Steven Hajdu (18)
  6. Oscar Lin (16)

More People

Years
  1. 2025 (3)
  2. 2024 (21)
  3. 2023 (37)
  4. 2022 (42)
  5. 2021 (31)
  6. 2020 (51)

More Years

Publications
  1. Oncology Research and Treatment (226)
  2. Cytogenetics and Cell Genetics (61)
  3. Acta Cytologica (58)
  4. Neuroendocrinology (51)
  5. Acta Haematologica (32)
  6. Onkologie (19)

More Publications

Results (633)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Resistance to type II JAK2 inhibition in MPN is dependent on MEK-ERK activation and is targetable
    Meeting Abstract

    Codilupi, T.; Szybinski, J.; Wicki, A.; Yang, J. L.; Ghosh, N.; Passweg, J.; Tsakiris, D.; Levine, R. L.; Koche, R.; Meyer, S. C.
    Oncology Research and Treatment (2020)

    Fulltext@MSK | Save
  • Exploratory analysis of retreatment with brentuximab vedotin (BV) after frontline treatment with brentuximab vedotin and CHP (A+CHP) for patients (pts) with CD30+ peripheral T-cell lymphoma (ECHELON-2)
    Meeting Abstract

    Trümper, L.; Pro, B.; Horwitz, S.; O'connor, O.; Tilly, H.; Choi, I.; Gritti, G.; Fox, C.; Alpdogan, O.; Mayer, J.; more...
    Oncology Research and Treatment (2020)

    Fulltext@MSK | Save
  • Dual genetic targeting of ERK1 and ERK2 abrogates the competitive potential of the myeloproliferative neoplasm clone
    Meeting Abstract

    Stivala, S.; Brkic, S.; Santopolo, A.; Dirnhofer, S.; Passweg, J.; Tsakiris, D.; Neel, B.; Levine, R.; Meyer, S.
    Oncology Research and Treatment (2020)

    Fulltext@MSK | Save
  • Announcement: The international system for reporting lymph node cytopathology
    Review

    Zeppa, P.; Cozzolino, I.; Caraway, N. P.; Al-Abbadi, M. A.; Barroca, H.; Bode-Lesniewska, B.; Calaminici, M.; Chhieng, D. F.; Ehinger, M.; Geddie, W. R.; more...
    Acta Cytologica (2020)

    Fulltext@MSK | Save
  • Update of radiation techniques using photons for anterior skull base tumors
    Journal Article

    Foster, C. C.; Kim, J. K.; Melotek, J. M.; Lee, N. Y.
    Advances in Oto-Rhino-Laryngology (2020)

    Fulltext@MSK | Save
  • Squamous cell carcinoma and its variants
    Journal Article

    Mani, N.; Shah, J. P.
    Advances in Oto-Rhino-Laryngology (2020)

    Fulltext@MSK | Save
  • A proposal for the performance, classification, and reporting of lymph node fine-needle aspiration cytopathology: The Sydney system
    Journal Article

    Al-Abbadi, M. A.; Barroca, H.; Bode-Lesniewska, B.; Calaminici, M.; Caraway, N. P.; Chhieng, D. F.; Cozzolino, I.; Ehinger, M.; Field, A. S.; Geddie, W. R.; more...
    Acta Cytologica (2020)

    Fulltext@MSK | Save
  • Neuroendocrine neoplasms of the small bowel and pancreas
    Journal Article

    Clift, A. K.; Kidd, M.; Bodei, L.; Toumpanakis, C.; Baum, R. P.; Oberg, K.; Modlin, I. M.; Frilling, A.
    Neuroendocrinology (2020)

    Fulltext@MSK | Save
  • Illustrating cancer risk: Patient risk communication preferences and interest regarding a novel BRCA1/2 genetic risk modifier test
    Journal Article

    Hamilton, J. G.; Genoff Garzon, M.; Shah, I. H.; Cadet, K.; Shuk, E.; Westerman, J. S.; Hay, J. L.; Offit, K.; Robson, M. E.
    Public Health Genomics (2020)

    Fulltext@MSK | Save
  • The use of deep learning and neural networks in imaging: welcome to the new mathematical milieu of medicine
    Editorial

    Modlin, I. M.; Kidd, M.; Drozdov, I. A.; Bodei, L.
    Neuroendocrinology (2020)

    Fulltext@MSK | Save